Literatur
-
1
Andersen V, Hegnhøj J H.
Identification
and quantification of serum proteins secreted into the normal human
jejunum.
Scand J Clin Lab Invest.
1990;
50
857-864
-
2
Andersen V, Hansen G H, Olsen J, Poulsen M D, Norén O, Sjöström H.
On
the transfer of serum proteins to the rat intestinal juice.
Scand J
Gastroenetrol.
1994;
29
430-436
-
3
Baba R, Hashimoto E, Yashiro K. et al .
Multiple
abdominal teleangiectases and lymphangiectases. A limited form of
Osler-Weber-Rendu disease?.
J Clin Gastroenterol.
1995;
21
154-157
-
4
Bac D J, van Hagen P M, Postema P TE, ten Bokum A MC, Zondervan P E, van Blankenstein M.
Octreotide
for protein-losing enteropathy with intestinal lymphangiectasia.
Lancet.
1995;
345
1639
-
5
Beaugrand M, Trinchet J C, Vaysse J, Hecht Y, Garnier M, Ferrier J P.
Mesure de
la clairance intestinale de l‘α-1-antitrypsine
chez 45 cirrhotiques alcooliques: fréquence et cause de
l’entéropathie exsudative.
Gastroenterol
Clin Biol.
1982;
6
62-67
-
6
Becker K, Lindner C, Frieling T, Niederau C, Reinauer H, Häussinger D.
Intestinal
protein leakage in the acquired immunodeficiency syndrome.
J
Clin Gastroenterol.
1997;
25
426-428
-
7
Becker K, Frieling T, Häussinger D.
Quantification
of fecal α1-antitrypsin excretion for assessment
of inflammatory bowel diseases.
Eur J Med Res.
1998;
3
65-70
-
8
Becker K, Berger M, Niederau C, Frieling T.
Individual
fecal α1-antitrypsin excretion reflects clinical
activity in Crohn’s disease, but not in ulcerative colitis.
Hepatogastroenterology.
1999;
46
2309-2314
-
9
Berkowitz I, Segal I.
Protein-losing enteropathy
in congestive cardiac failure: an entity of minor clinical significance.
Am
J Gastroenterol.
1990;
85
154-156
-
10
Boirivant M, Pallone F, Ciaco A, Leoni M, Fais S, Torsoli A.
Usefulness
of fecal (α1-antitrypsin clearance and fecal concentration
as early indicator of postoperative asymptomatic recurrence in Crohn’s
disease.
Dig Dis Sci.
1991;
36
347-352
-
11
Cellier C, Sahmoud T, Froguel E. et al .
Correlations between clinical activity,
endoscopic severity, and biological parameters in colonic or ileocolonic
Crohn’s disease. A prospective multicentre study of 121
cases.
Gut.
1994;
35
231-235
-
12
Crossley J R, Elliott R B.
Simple method
for diagnosing protein-losing enteropathies.
Brit Med
J.
1977;
1
428-429
-
13
Da Costa L R, Croft D N, Creamer B.
Protein
loss and cell loss from the small-intestinal mucosa.
Gut.
1971;
12
179-183
-
14
Davidson J D, Waldmann T A, Goodman D S, Gordon R S.
Protein-losing
gastroenteropathy in congestive heart-failure.
Lancet.
1961;
i
899-902
-
15
Dinari G, Rosenbach Y, Zahavi I, Sivan Y, Nitzan M.
Random
fecal α1-antitrypsin excretion in children with
intestinal disorders.
Am J Dis Child.
1984;
138
971-973
-
16
Dournovo P, Mignon M, Favriel J M, Rambaud J C.
Maladie de
Ménétrier: traitement au long cours par la cimétidine.
Nouv
Presse Méd.
1980;
9
1241
-
17
Durie P R.
Intestinal
protein loss and fecal α1-antitrypsin.
J
Pediatr Gastroenterol Nutr.
1985;
4
345-347
-
18
Gordon R S.
Exudative
enteropathy. Abnormal permeability of the gastrointestinal tract
demonstrable with labelled polyvinylpyrrolidone.
Lancet.
1959;
1
325-326
-
19
Halaby H, Bakheet S M, Shabib S, Powe J E, Al M ehaidib
A, Nazer H.
99mTc-human
serum albumin scans in children with protein-losing enteropathy.
J
Nucl Med.
2000;
41
215-219
-
20
Itoi K, Sasaki T, Sawai T. et al .
Protein-losing
gastroenteropathy in association with immune deposits in gastrointestinal
mucosal capillaries.
Am J Gastroenterol.
1989;
84
187-191
-
21 Jeejeebhoy K N. Plasma
proteins and gastrointestinal tract in health and disease. Munksgaard,
Copenhagen in: Schwartz M, Vesin P (eds.) 1962: 59
-
22
Jeffries G H, Chapman A, Sleisenger M H.
Low-fat
diet in intestinal lymphangiectasia. Its effect on albumin metabolism.
N
Eng J Med.
1964;
270
761-766
-
23
Karbach U, Ewe K.
Enteric protein loss in
various gastrointestinal diseases determined by intestinal alpha1-antitrypsin
clearance.
Z Gastroenetrol.
1989;
27
362-365
-
24
Kelly D G, Miller L J, Malagelada J R, Huizenga K A, Markowitz H.
Giant
hypertrophic gastropathy (Ménétrier’s
disease): pharmacologic effects on protein leakage and mucosal ultrastructure.
Gastroenterology.
1982;
83
581-589
-
25
King C E, Toskes P P.
Protein-losing
enteropathy in the human and experimental rat blind-loop syndrome.
Gastroenterology.
1981;
80
504-509
-
26
Krag E, Frederiksen H J, Olsen N, Henriksen J H.
Cimetidine
treatment of protein-losing gastropathy (Ménétrier’s
disease). A clinical and pathophysiological study.
Scand
J Gastroenterol.
1978;
13
635-639
-
27
Laine L, Politoske E J, Gill P.
Protein-losing enteropathy
in acquired immunodeficiency syndrome due to intestinal Kaposi’s
sarcoma.
Arch Intern Med.
1987;
147
1174-1175
-
28
MacFarlane G T, Cummings J H, Allison C.
Protein
degradation by human intestinal bacteria.
J Gen Microbiol.
1986;
132
1647-1656
-
29
Meyers S, Lichtiger S, Feuer E J, Lahman E A, Janowitz H D.
Fecal α 1
-antitrypsin as a measure of Crohn’s disease
activity. The effect of therapy and anatomical extent of disease.
J
Clin Gastroenterol.
1988;
10
491-497
-
30
Moran A, Jones A, Asquith P.
Laboratory markers of
colonoscopic activity in ulcerative colitis and Crohn’s
colitis.
Scand J Gastroenterol.
1995;
30
356-360
-
31
Munro D R.
Route
of protein loss during a model protein-losing gastropathy in dogs.
Gastroenterology.
1974;
66
960-972
-
32
Prigent-Delecourt L, Coffin B, Colombel J F, Dehennin J P, Vaerman J P, Rambaud J C.
Secretion
of immunoglobulins and plasma proteins from the colonic mucosa:
an in vivo study in man.
Clin Exp Immunol.
1995;
99
221-225
-
33
Riva G, Barandun S, Koblet H, Nusslé D, Witschi H P.
Proteinverlierende
Gastroenteropathien: Klinik und Pathophysiologie.
Prot
Biol Fluids.
1963;
11
168-192
-
34
Saitoh O, Matsumoto H, Sugimori K. et al .
Intestinal protein loss and bleeding assessed
by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin
levels in patients with colorectal diseases.
Digestion.
1995;
56
67-75
-
35
Schmidt P N, Blirup-Jensen S, Svendsen P J, Wandall J H.
Characterization
and quantification of plasma proteins excreted in faeces from healthy
humans.
Scand J Clin Lab Invest.
1995;
55
35-45
-
36
Strygler B, Nicar M J, Santangelo W C, Porter J L, Fordtran J S.
α 1
-Antitrypsin excretion in stool in normal subjects and
in patients with gastrointestinal disorders.
Gastroenterology.
1990;
99
1380-1387
-
37
Stufler M HM, Ewe K, Gierlasinski B, Prün H, Zutt M.
Erhöhtes
Serum-α-1-Antitrypsin verursacht bei darmgesunden Patienten
keinen Anstieg des fäkalen α-1-Antitrypsin.
Z
Gastroenterol.
1991;
29
11-15
-
38
Thomas D W, Sinatra F R, Merritt R J.
Random
fecal alpha-1-antitrypsin concentration in children with gastrointestinal
disease.
Gastroenterology.
1981;
80
776-782
-
39
Van Dellen R G, Lewis J C.
Oral administration
of cromolyn in a patient with protein-losing enteropathy, food allergy,
and eosinophilic gastroenteritis.
Mayo Clin Proc.
1994;
69
441-444
-
40
Waldmann T A.
Gastrointestinal
protein loss demonstrated by Cr-51 labelled albumin.
Lancet.
1961;
2
121-123
-
41
Waldmann T A, Wochner R D, Strober W.
The
role of the gastrointestinal tract in plasma protein metabolism.
Studies with 51Cr-albumin.
Am J Med.
1969;
46
275-285
-
42
Wetterfors J, Gullberg R, Liljedahl S O, Plantin L O, Birke G, Olhagen B.
Role of the stomach
and small intestine in albumin breakdown.
Acta Med Scand.
1960;
168
347-363
-
43
Wilkinson P, Pinto B, Senior J R.
Reversible
protein-losing enteropathy with intestinal lymphangiectasia secondary
to chronic constrictive pericarditis.
N Engl J Med.
1965;
273
1178-1181
-
44 Wilson T H. Intestinal
absorption. Saunders, Philadelphia/London 1962: 110-111
Korrespondenz
Dr. med. Klaus Becker
Klinik für Innere Medizin und Gastroenterologie, Florence-Nightingale-Krankenhaus, Kaiserswerther
Diakonie
Kreuzbergstraße 79
40489 Düsseldorf
Phone: 0211/409-2500
Fax: 0211/409-2342
Email: becker@kaiserswerther-diakonie.de
